Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chase Cannon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
JMIR Research Protocols|September 23, 2024
Implementation and Evaluation of a Home-Based Pre-Exposure Prophylaxis Monitoring Option: Protocol for a Randomized Controlled TrialChase Cannon, Katherine Holzhauer, Matthew Golden
Sexually Transmitted Diseases|July 1, 2025
Use of Doxycycline for STI Post-Exposure Prophylaxis in People Assigned Female at Birth in the United StatesAniruddha Hazra, Chase Cannon, Jason Bena, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2025
Preferences for HIV PrEP Products and Delivery Models Among Cisgender Men, Transgender Persons, and Non-binary Individuals Who Have Sex with Men in Seattle, Washington: A Discrete Choice ExperimentLauren R Violette, Jakar Delacruz, Lisa A Niemann, et al.
AIDS Patient Care and Stds|April 24, 2024
Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial ParticipantsRob J Fredericksen, Rodney Perkins, Clare E Brown, et al.
Research Square|May 3, 2024
Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistomeCharles Langelier, Victoria Chu, Abigail Glascock, et al.
Sexually Transmitted Diseases|February 1, 2024
Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara VaccineMatthew R Golden, Olusegun O Soge, Margaret Mills, et al.
Nature Medicine|October 3, 2024
Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistomeVictoria T Chu, Abigail Glascock, Deborah Donnell, et al.
The Lancet. Infectious Diseases|March 27, 2025
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extensionAnne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
JMIR Research Protocols|September 23, 2024
Implementation and Evaluation of a Home-Based Pre-Exposure Prophylaxis Monitoring Option: Protocol for a Randomized Controlled TrialChase Cannon, Katherine Holzhauer, Matthew Golden
Sexually Transmitted Diseases|July 1, 2025
Use of Doxycycline for STI Post-Exposure Prophylaxis in People Assigned Female at Birth in the United StatesAniruddha Hazra, Chase Cannon, Jason Bena, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2025
Preferences for HIV PrEP Products and Delivery Models Among Cisgender Men, Transgender Persons, and Non-binary Individuals Who Have Sex with Men in Seattle, Washington: A Discrete Choice ExperimentLauren R Violette, Jakar Delacruz, Lisa A Niemann, et al.
AIDS Patient Care and Stds|April 24, 2024
Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial ParticipantsRob J Fredericksen, Rodney Perkins, Clare E Brown, et al.
Research Square|May 3, 2024
Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistomeCharles Langelier, Victoria Chu, Abigail Glascock, et al.
Sexually Transmitted Diseases|February 1, 2024
Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara VaccineMatthew R Golden, Olusegun O Soge, Margaret Mills, et al.
Nature Medicine|October 3, 2024
Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistomeVictoria T Chu, Abigail Glascock, Deborah Donnell, et al.
The Lancet. Infectious Diseases|March 27, 2025
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extensionAnne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, et al.
Pageof 1